Ophthotech reported $141.11M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Alimera Sciences ALIM:US $ 7.86M 2.09M
Applied Genetic Technologies AGTC:US $ 67.85M 4.92M
Bioline Rx BLRX:US $ 11.45M 1.54M
Cytrx CYTR:US 5.08M 1.69M
Insmed INSM:US $ 416.08M 99.63M
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Novartis NOVN:VX SF 3625M 10227M
Ophthotech OPHT:US $ 141.11M 50.75M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M